Has Adam Lukasiewicz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,008 in general payments to Adam Lukasiewicz, MD across 76 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Adam Lukasiewicz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Adam Lukasiewicz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Adam Lukasiewicz, MD

Foot and Ankle Surgery · Birmingham, ALNPI 1558718601

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (48.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Arthrex at 48.3% of the total. Reporting peaked in 2022 at $7,592 and has fallen 79.2% since, to $1,582 in 2025.

$10,008in general payments, 2019–2025

Across 76 payments — averaging $131.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$5K
Stryker$2K
Supreme Orthopedic Systems, LLC$1K
Encore Medical, LP$584
Paragon 28, Inc.$465
Exactech, Inc.$273
plus $1K from 16 others

What the payments were for

Travel & lodging$1,48315%
Food & beverage$3,72537%
Education$4,80048%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	17	$4,831
Stryker	21	$1,585
Supreme Orthopedic Systems, LLC	2	$1,212
Encore Medical, LP	1	$584
Paragon 28, Inc.	6	$465
Exactech, Inc.	2	$273
Smith+Nephew	2	$177
Johnson & Johnson	3	$160
Davol Inc.	1	$133
Sanara Medtech Inc.	1	$127
Orthofix Medical, Inc.	2	$77
Pacira Pharmaceuticals Incorporated	3	$61
Vertex	3	$58
Bioventus LLC	2	$47
Convatec Inc.	2	$42
Illuminoss Medical, Inc.	1	$37
Amgen	2	$35
SPR Therapeutics, Inc	1	$31
Molnlycke Health Care US, LLC	1	$26
Solventum Corporation	1	$18
Conmed Corporation	1	$18
Kerecis Limited	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DJO SURGICAL$584
AUGMENT INJECTABLE$536
VANTAGE$273
NA$217
PANGEA$175
TOTAL TALUS$175
ORTHOLOC 3DI$156
GRAVITY SYNCHFIX$148
Bioinductive Implant with Arthroscopic Delivery System - Medium$142
Q-FIX$142
ARISTA AH FLEXITIP$133
CellerateRx$127
Bun-Yo-Matic$121
INFINITY$120
MOTOBAND$108
HAMMERLOCK$108
CARTIVA SYNTHETIC CARTILAGE IMPLANT$101

How this compares

$10,008 in reported general payments places this provider in the 70th percentile of 40 foot and ankle surgery providers in Alabama.

See all foot and ankle surgery providers in Alabama →

Medicare billing

Part B allowed, 2024

$81,894

Medicare patients

221

Services billed

1,048

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	164	$674
Gabapentin	68	$605
Duloxetine Hcl	24	$311
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	50	$297
Meloxicam	66	$270
Cefadroxil	30	$230
Ondansetron Hcl	68	$175

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Birmingham

Norman WaldropBirmingham$3.6M
Ashish ShahBirmingham$28K
Swapnil SinghBirmingham$14K
Mary GilmerBirmingham$8K
Danalynn GuasteferroBirmingham$5K
Kenneth UngerBirmingham$4K
Francisco CaycedoBirmingham$3K
Ronald AgeeBirmingham$2K
Justin DaigreDecatur$372K
John KirchnerHoover$84K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →